Helicobacter pylori infection in childhood: Results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 11, 2000, Pages 1243-1250

  Nijevitch, Alexander A ^a,c   Farztdinov, Karim M ^a   Sataev, Valery U ^a   Khasanov, Rinat Sh ^a   Katayev, Valery A ^b   Khusnutdinov, Shamil M ^a   Akhunov, Eduard D ^b   Kazykhanov, Nasghat S ^b  

^a Children's Republican Hospital Ufa   (Russian Federation)

^b BASHKIR STATE MEDICAL UNIVERSITY   (Russian Federation)

^c NONE   (Russian Federation)

Author keywords

Amoxicillin; Helicobacter pylori; Pediatrics; Peptic ulcer; Ranitidine bismuth citrate; Tinidazole

Indexed keywords

AMOXICILLIN; RANITIDINE BISMUTH CITRATE; TINIDAZOLE;

ADOLESCENT; ARTICLE; BACTERIUM DETECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; ENDOSCOPY; FEMALE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PEPTIC ULCER; PRIORITY JOURNAL; SCHOOL CHILD; TASTE DISORDER;

EID: 0033664381     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02326.x     Document Type: Article

References (47)

1. Peptic ulcer - An infectious disease?
2. Helicobacter pylori infection in children: A clinical overview
3. Helicobacter pylori-dependent intragastric urea biodegradation in children: Diagnostic and pathogenetic importance
4. Campylobacter pylori-associated gastritis and peptic ulcer disease in children
5. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin
6. Helicobacter pylori-associated gastritis in Kuwait: Endoscopy-based study in symptomatic and asymptomatic children
7. Helicobacter pylori infection in children
8. Helicobacter pylori infection in children. Author's eply
9. Helicobacter pylori in the pediatric patient
10. Helicobacter pylori infection and chronic gastritis: Clinical, serologic, and histologic correlation in children treated with amoxicillin and colloidal bismuth subcitrate
11. Oral triple therapy (OTT) may effectively eradicate Campylobacter pylori (CP) in man: A pilot study
12. Helicobacter pylori in peptic ulcer disease
13. Effects of Ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection
14. Pathophysiology of childhood duodenal ulcer
15. Esophagitis and Helicobacter pylori in children: Incidence and therapeutic implications
16. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease
17. Canadian Helicobacter study group consensus conference on the approach to Helicobacter pylori infection in children and adolescents
18. Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori in infected volunteers
19. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcer, eradicating H. pylori and reducing ulcer recurrence
20. Dual and triple therapy regimens of antisecretory agents and antibiotics for the eradication of Helicobacter pylori: An overview
21. The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori
22. Consideration of Helicobacter pylori infection in childhood: Immune response, endoscopic and morphological findings
23. Helicobacter pylori infection in children: Potential clues to pathogenesis
24. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens
25. Gastric cancer and premalignant lesions in atrophic gastritis: A controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene
26. 'De-Nol test' for rapid diagnosis of Helicobacter pylori in childhood
27. Detection and identification of Helicobacter pylori by the polymerase chain reaction
28. Intragastric urea hydrolysis in children infected with Helicobacter pylori
29. Ranitidine bismuth citrate and clarithromycin twice daily in eradication of Helicobacter pylori
30. Incidence of side-effects during bismuth subsalicylate and antibiotic therapy for H. Pylori (HP)
31. Helicobacter pylori gastritis in dyspeptic children. A long-term follow-up after treatment with colloidal bismuth subcitrate and tinidazole
32. Peptic ulcer disease in childhood
33. Helicobacter pylori infection in children
34. Ranitidine bismuth citrate: A novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture
35. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate
36. Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer
37. Trough plasma bismuth concentrations in peptic ulcer patients treated with ranitidine bismuth citrate (GR122311X)
38. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant, and tri-potassium dicitrato bismuthate (TDB)
39. One-week ranitidine bismuth citrate versus colloidal bismuth subcitratetriple therapy: A prospective based anti-Helicobacter randomized controlled trial
40. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents, against Campylobacter pyloridis
41. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate
42. Effect of acid supression on efficacy of treatment for Helicobacter pylori infection
43. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain)
44. Helicobacter pylori and associated duodenal ulcer
45. Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates
46. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: The RBC-MACH study
47. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): A randomized comparison between two 7-day triple therapies and a 14-day dual therapy